Table 4.
Multivariate analysis of factors affecting PFS and OS in high-risk patients
Risk factor | PFS |
OS |
||||
---|---|---|---|---|---|---|
HR | 95% CI | p-value | HR | 95% CI | p-value | |
Age ≥ 12 mo | 0.56 | 0.12-2.62 | 0.458 | 0.27 | 0.07-1.11 | 0.069 |
Unfavorable pathology | 1.35 | 0.47-3.89 | 0.582 | 2.98 | 0.75-11.88 | 0.122 |
MYCN amplification | 0.97 | 0.37-2.55 | 0.949 | 1.84 | 0.75-4.50 | 0.181 |
PB TH-positive at diagnosis | 9.02 | 2.06-39.50 | 0.004 | 3.54 | 1.26-9.93 | 0.016 |
PFS, progression-free survival; OS, overall survival; HR, hazard ratio; CI, confidence interval; PB, peripheral blood; TH, tyrosine hydroxylase.